Leading proprietary investor conference series Virtual Investor Conferences (VIC) has partnered with KCSA Strategic Communications to announce the agenda for the upcoming KCSA Psychedelics Virtual Investor Conference which has been slated for April 27-28, 2022.
VIC offers an interactive forum for publicly traded companies to seamlessly present directly to investors while KCSA is a fully integrated communications agency specializing in public relations, investor relations and social media with expertise in financial and professional services, technology, healthcare, digital media and cannabis.
According to the announcement made on April 25, analysts, advisors, individual and institutional investors have been invited to take part in the two-day virtual event which will be showcasing live company presentations and interactive discussions focused on psychedelic treatments for mental health disorders.
“As we have seen over the past 18 months, drug development is hard. The good news is many of the companies presenting over the two-day event have shown tremendous clinical progress. I would encourage investors to take a traditional pharma or biotech view of this space and practice patience, do the proper diligence, and the rewards will be tremendous,” said the founder and managing partner of KCSA’s Psychedelics Practice, Lewis Goldberg.
Those willing to participate in the conference can submit their application here. In addition, to enable investor scheduling and to view a complete calendar of Virtual Investor Conferences one can visit www.virtualinvestorconferences.com
